Summary of all studies containing PUBCHEM ID 6441392
| Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
|---|---|---|---|---|---|
| PR000519 | ST000722 | Metabolomics of Diapause in Aedes albopictus | Insect | Aedes albopictus | OLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000256 | ST000317 | Role of medium in bacterial growth | Bacterial cells | Bacteria | Acylcarnitine C18:1 [Data] |
| PR000261 | ST000323 | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 2:Uterine flush) | Animal | Bos taurus | Acylcarnitine C18:1 [Data] |
| PR002020 | ST003254 | The impact of grass- and grain-finishing on metabolomic profiles of North American Black Angus Beef cattle. | Mammal | Bos taurus | oleoylcarnitine (C18:1) [Data] |
| PR002182 | ST003546 | Improved Soil Health and Pasture Phytochemical Richness Underlies Improved Beef Nutrient Density in Southern US Grass-Finished Beef Systems | Mammal | Bos taurus | oleoylcarnitine (C18:1) [Data] |
| PR000263 | ST000328 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Animal | Canis lupus familiaris | Acylcarnitine C18:1 [Data] |
| PR000015 | ST000016 | NPM-ALK metabolic regulation | Human | Homo sapiens | OLEOYLCARNITINE [Data] |
| PR000041 | ST000042 | BALF Control vs ALI by RPLC-MS | Human | Homo sapiens | OLEOYLCARNITINE (*) [Data] |
| PR000043 | ST000044 | Pilot experiment looking for the existence of certain molecules in pancreatic cancer cells | Human | Homo sapiens | OLEOYLCARNITINE (*) [Data] |
| PR000058 | ST000081 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of subcutaneous and visceral adipose tissue samples | Human | Homo sapiens | Acylcarnitine C18:1 [Data] |
| PR000058 | ST000082 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of serum samples | Human | Homo sapiens | Acylcarnitine C18:1 [Data] |
| PR000079 | ST000089 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis | Human cells | Homo sapiens | Acylcarnitine C18:1 [Data] |
| PR000097 | ST000105 | SCOR Metabolomics | Human | Homo sapiens | OLEOYLCARNITINE (*) [Data] |
| PR000098 | ST000106 | IWMS Study 1:Weight comparison of obese and lean patients | Human | Homo sapiens | OLEOYLCARNITINE (*) [Data] |
| PR000154 | ST000199 | IDH1 and Glioma knockdown idh1 (part II) | Human | Homo sapiens | Oleoylcarnitine [Data] |
| PR000264 | ST000329 | Minimal change disease and focal segmental sclerosis in urine | Human | Homo sapiens | Acylcarnitine C18:1 [Data] |
| PR000278 | ST000346 | Metabolites detected from human bronchoalveolar lavage | Animal | Homo sapiens | Acylcarnitine C18:1 [Data] |
| PR000386 | ST000523 | Prenatal exposures and Metabolite and Lipid Profiles | Animal | Homo sapiens | OLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000495 | ST000698 | Metabolomics analysis of Sirt5 knockdown (KD) melanoma | Human | Homo sapiens | OLEOYLCARNITINE (*) (CAS# 13962-05-5); (M+H)+ [Data] |
| PR000522 | ST000725 | Metabolome, body composition, and muscle performance in children | Human | Homo sapiens | OLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000536 | ST000743 | Metabolomics of bariatric weight loss | Human | Homo sapiens | OLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000537 | ST000744 | Metabolomics of intensive weight management clinic (IWMC) weight loss | Human | Homo sapiens | OLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000556 | ST000770 | Intranasal oxytocin in lean and obese men | Human | Homo sapiens | OLEOYLCARNITINE [Data] |
| PR000557 | ST000771 | Looking for changes in lipid levels with knock out of ACADM (shACADM) | Human | Homo sapiens | OLEOYLCARNITINE [Data] |
| PR000557 | ST000819 | Looking for changes in lipid levels with knock out of ACADM (shACADM) (part II) | HUMAN | Homo sapiens | OLEOYLCARNITINE [Data] |
| PR000561 | ST000775 | Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study | Human | Homo sapiens | OLEOYLCARNITINE (*) (CAS# 13962-05-5); (M+H)+ [Data] |
| PR000583 | ST000818 | Integrated nutrigenomic and metabolomic analysis of Africans with variable diet | HUMAN | Homo sapiens | OLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000599 | ST000841 | Metabolomics of muscle in insulin sensitive and resistant obese indivduals. | HUMAN | Homo sapiens | OLEOYLCARNITINE [Data] |
| PR000599 | ST000842 | Muscle and plasma before and after exercise | HUMAN | Homo sapiens | OLEOYLCARNITINE [Data] |
| PR000625 | ST000899 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Human serum | Homo sapiens | oleoylcarnitine [Data] |
| PR000649 | ST000944 | Amino Acids, Acylcarnitine, & Insulin for P20 Participants | Human | Homo sapiens | OLEOYLCARNITINE [Data] |
| PR000651 | ST000946 | Untargeted Metabolomics of T1 Participants | Human | Homo sapiens | OLEOYLCARNITINE (M+H) [Data] |
| PR000907 | ST002089 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR000960 | ST001400 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR000960 | ST001516 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR000960 | ST001517 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR000967 | ST001411 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR000968 | ST001412 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR001022 | ST001515 | A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans | Human | Homo sapiens | oleoylcarnitine (C18) [Data] |
| PR001048 | ST001639 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR001048 | ST002088 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR001121 | ST001749 | REACH Metabolomics Study | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR001159 | ST001835 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Human | Homo sapiens | oleoylcarnitine (C18) [Data] |
| PR001228 | ST001940 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR001235 | ST001948 | Metabolites Associated with Gestational Diabetes in Plasma | Human | Homo sapiens | CAR 18:1 [Data] |
| PR001282 | ST002019 | TIPs Metabolomics (blood) | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR001613 | ST002498 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR001762 | ST002818 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR001762 | ST002820 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR001769 | ST002827 | Multi-assay nutritional metabolomics profiling of low vitamin A status versus adequacy is characterized by reduced plasma lipid mediators among lactating women in the Philippines: A pilot study. | Human | Homo sapiens | Oleyl-carnitine [Data] |
| PR001771 | ST002829 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR001809 | ST002909 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR002165 | ST003520 | Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR002450 | ST003917 | Gut Microbial Bile and Amino Acid Metabolism Associate with Peanut Oral Immunotherapy Failure | Human | Homo sapiens | oleoylcarnitine (C18:1) [Data] |
| PR000054 | ST000075 | Combined Metabolomics and Lipidomics of Type 1 Diabetes (QTOF) | Animal | Mus musculus | Acylcarnitine C18:1 [Data] |
| PR000139 | ST000160 | Basic Metabolism Studies (wt and TPA null) | Animal | Mus musculus | Oleoylcarnitine [Data] |
| PR000153 | ST000211 | T cell metabolism during graft-versus-host disease (CAB 307)-PART II | Animal | Mus musculus | Oleoylcarnitine [Data] |
| PR000156 | ST000201 | Bone Marrow Metabolomics (part II) | Animal | Mus musculus | Oleoylcarnitine [Data] |
| PR000169 | ST000198 | Liver and Plasma metaboites for 13C-glucose load in wild type, LIRKO and LIRFKO mice | Animal | Mus musculus | Oleoylcarnitine [Data] |
| PR000198 | ST000245 | Acyl-Carnitine Analysis in mouse soleus muscle | Animal | Mus musculus | Oleoylcarnitine [Data] |
| PR000216 | ST000272 | Acyl-carnitine analysis (plasma) | Animal | Mus musculus | Oleoylcarnitine [Data] |
| PR000240 | ST000299 | Conjugated linoleic acid (CLA) study in LDLR-/- mice | Animal | Mus musculus | CAR(18:1) [Data] |
| PR000260 | ST000321 | Effects of LGG on current drinkers gut metabolism | Animal | Mus musculus | Acylcarnitine C18:1 [Data] |
| PR000265 | ST000330 | Effects of Zinc on GI tract metabolites (Part 1: Esophagus) | Animal | Mus musculus | Acylcarnitine C18:1 [Data] |
| PR000265 | ST000331 | Effects of Zinc on GI tract metabolites (Part 2: Prostate) | Animal | Mus musculus | Acylcarnitine C18:1 [Data] |
| PR000266 | ST000332 | Effects of Giardia intestinalis on mice GI tract | Animal | Mus musculus | Acylcarnitine C18:1 [Data] |
| PR000295 | ST000374 | Mice exercise metabolomics (part I) | Animal | Mus musculus | OLEOYLCARNITINE [Data] |
| PR000349 | ST000451 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data | Animal | Mus musculus | Oleoylcarnitine [Data] |
| PR000349 | ST000452 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data | Animal | Mus musculus | Oleoylcarnitine [Data] |
| PR000529 | ST000732 | Acylcarnitine profile in fast-refed livers | MOUSE | Mus musculus | OLEOYLCARNITINE [Data] |
| PR000541 | ST000751 | Mouse placentas-DEHP exposure | Mouse | Mus musculus | OLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000591 | ST000830 | CD47 WT/KO muscle and serum acyl-carnitine assay | MOUSE | Mus musculus | OLEOYLCARNITINE [Data] |
| PR000598 | ST000838 | Obesity and marrow and marrow adipose tissue (MAT) metabolomics | MOUSE | Mus musculus | OLEOYLCARNITINE [Data] |
| PR000764 | ST001143 | Microbial depletion and ozone exposure - Lung tissue (part I) | Mammal | Mus musculus | oleoylcarnitine [Data] |
| PR000764 | ST001144 | Microbial depletion and ozone exposure - serum (part II) | Mammal | Mus musculus | oleoylcarnitine [Data] |
| PR000776 | ST001157 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Mammal | Mus musculus | oleoylcarnitine (C18) [Data] |
| PR000776 | ST001158 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Mammal | Mus musculus | oleoylcarnitine (C18) [Data] |
| PR000840 | ST001253 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR001129 | ST001775 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR001488 | ST002322 | Metabolomics study comparing SCAP KO and WT B cells | Cultured cells | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR001715 | ST002754 | Metabolomics analysis of maternal obesity model | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR001764 | ST002822 | Effect of ERR Agonist in Mouse Heart Post Pressure Overload | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR001776 | ST002836 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Intestine) | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR001776 | ST002837 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Blood) | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR001945 | ST003131 | Untargeted Metabolomics on mouse caecal contents | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR001945 | ST003132 | Untargeted Metabolomics on Mouse colonic mucosa | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR001952 | ST003277 | LC-MS/MS spatial analysis of mouse GI | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR002118 | ST003426 | Metabolomic and transcriptomic remodeling of bone marrow myeloid cells in response to maternal obesity | Mammal | Mus musculus | CAR 18:1 [Data] |
| PR002210 | ST003580 | Metabolomic profiling of normal and fibrotic mouse lungs | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR002460 | ST003927 | Histidine decarboxylase inhibition attenuates cancer-associated muscle wasting | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR002527 | ST004035 | Serum Metabolites at Defined Stages of Liver Disease | Mammal | Mus musculus | oleoylcarnitine (C18:1) [Data] |
| PR001756 | ST002809 | Role of cilia in mitochondrial function | Mammal | Mus musculus;Canis lupus familiaris | oleoylcarnitine (C18:1) [Data] |
| PR000238 | ST000297 | Intestinal lipid oxidation after VSG | Animal | Rattus norvegicus | CAR(18:1) [Data] |
| PR000275 | ST000343 | Modification of metabolites by gut microbiota in response to diet | Animal | Rattus norvegicus | Acylcarnitine C18:1 [M+H]+ [Data] |
| PR000540 | ST000749 | Rat amniotic fluid metabolomics | Rat | Rattus norvegicus | OLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000540 | ST000750 | Rat amniotic fluid metabolomics (part II) | Rat | Rattus norvegicus | OLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000547 | ST000758 | Effects of caloric restriction in HCR/LCR rats | Rat | Rattus norvegicus | OLEOYLCARNITINE (*) (CAS# 13962-05-5); (M+H)+ [Data] |
| PR001118 | ST001745 | Metabolomic profiling of the rat hippocampus across developmental ages and after learning | Mammal | Rattus norvegicus | oleoylcarnitine (C18:1) [Data] |
| PR001180 | ST001869 | WNK463 Inhibition on Right Ventricular metabolomics | Mammal | Rattus norvegicus | oleoylcarnitine (C18:1) [Data] |
| PR001180 | ST001870 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Mammal | Rattus norvegicus | oleoylcarnitine (C18:1) [Data] |
| PR002278 | ST003673 | Identification of plasma metabolites responding to oxycodone exposure in rats | Other organism | Rattus norvegicus | oleoylcarnitine (C18:1) [Data] |